- Home
- ADC vs PEN Comparison
ADC vs PEN Comparison
Compare ADC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADC
- PEN
- Stock Information
- Founded
- ADC 1971
- PEN 2004
- Country
- ADC United States
- PEN United States
- Employees
- ADC N/A
- PEN N/A
- Industry
- ADC Real Estate Investment Trusts
- PEN Medical/Dental Instruments
- Sector
- ADC Real Estate
- PEN Health Care
- Exchange
- ADC Nasdaq
- PEN Nasdaq
- Market Cap
- ADC 8.5B
- PEN 9.0B
- IPO Year
- ADC 1994
- PEN 2015
- Fundamental
- Price
- ADC $73.71
- PEN $242.93
- Analyst Decision
- ADC Buy
- PEN Strong Buy
- Analyst Count
- ADC 14
- PEN 16
- Target Price
- ADC $80.42
- PEN $300.47
- AVG Volume (30 Days)
- ADC 1.2M
- PEN 531.0K
- Earning Date
- ADC 07-31-2025
- PEN 07-29-2025
- Dividend Yield
- ADC 4.12%
- PEN N/A
- EPS Growth
- ADC N/A
- PEN 915.21
- EPS
- ADC 1.68
- PEN 3.74
- Revenue
- ADC $659,754,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- ADC $13.16
- PEN $14.60
- Revenue Next Year
- ADC $11.25
- PEN $14.24
- P/E Ratio
- ADC $43.83
- PEN $64.87
- Revenue Growth
- ADC 13.16
- PEN 12.92
- 52 Week Low
- ADC $67.58
- PEN $160.18
- 52 Week High
- ADC $79.65
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ADC 53.78
- PEN 50.26
- Support Level
- ADC $71.48
- PEN $225.48
- Resistance Level
- ADC $74.43
- PEN $261.81
- Average True Range (ATR)
- ADC 1.20
- PEN 6.51
- MACD
- ADC 0.15
- PEN 2.63
- Stochastic Oscillator
- ADC 78.05
- PEN 48.03
About ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.